生物科技公司薛定谔（Schrodinger Inc.，股票代码：SDGR）今日盘前股价大涨5.07%，主要受到公司发布的第二季度财报超出市场预期的推动。
根据公司公布的财报显示，截至6月30日的第二季度，薛定谔调整后每股亏损为0.59美元，明显好于分析师平均预期的0.77美元亏损。公司季度总收入同比增长15.7%，达到5476万美元，同样超过了市场预期的5200万美元。其中，软件收入为4050万美元，同比增长15%；药物发现收入为1420万美元，同比增长19%。
尽管公司仍录得4317万美元的季度亏损，但整体业绩表现优于预期。公司管理层维持2025年全年软件收入增长10%-15%的指导，药物发现收入预计在4500万至5000万美元之间。分析师对公司前景持积极态度，目前对该公司股票的平均评级为"买入"，华尔街给出的12个月目标价中位数为31.00美元，较最新收盘价19.64美元高出约36.6%。这种乐观情绪可能会进一步支撑股价的上涨势头。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.